Advantages of sensor ‐augmented insulin pump therapy for pregnant women with type 1 diabetes mellitus
ConclusionThe present study showed that SAP therapy is more effective in preventing large for gestational age newborns in pregnant women with type 1 diabetes mellitus than CSII/SMBG.
Source: Journal of Diabetes Investigation - Category: Endocrinology Authors: Hitomi Imafuku,
Kenji Tanimura,
Naohisa Masuko,
Masako Tomimoto,
Yutoku Shi,
Akiko Uchida,
Masashi Deguchi,
Kazumichi Fujioka,
Akane Yamamoto,
Kei Yoshino,
Yushi Hirota,
Wataru Ogawa,
Yoshito Terai Tags: Original Article Source Type: research
More News: Diabetes | Diabetes Mellitus | Endocrinology | Insulin | OBGYN | Perinatology & Neonatology | Pregnancy | Respiratory Medicine | Study | Women